Skip to main content

Table 1 General characteristics and comparison of patients in cases with NMO (n = 11) and control arm (n = 18)

From: Relevance of bright spotty lesions in neuromyelitis optica spectrum disorders (NMOSD): a case series

Variable

n (%)

Age ratio (Above and equal to 50: below 50)

 

 Cases group

8:3

 Control Group

7:11

Gender (Female and Male ratio)

 

 Cases group

11:0

 Control group

10:8

MRI spine findings—presence of bright spotty lesions

 

 Cases group

5(45.45%)

 Control group

0

MRI spine findings—presence of LETM

 

 Cases group

10 (90.9%)

 Control group

0

Presence of BSLs and LESCL in Cases Group (NMO) (n = 5)

 

 BSLs with LETM

4(80%)

 BSLs without LETM

1(20%)

Seropositivity for NMO antibodies

 

 Cases Group

11(100%)

 Control group

0

Recovery (Partial recovery: full recovery)

 

 Cases group

10:1

 Control group

13:5

  1. NMO: neuromyelitis optica; BSLs: bright spotty lesions, LETM: longitudinal extensive transverse myelitis